Concarlo Therapeutics Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
2ndary - Private
- Investors
-
7
Concarlo Therapeutics General Information
Description
Operator of a precision-medicine oncology firm intended to bring a precision medicine approach to breast cancer management. The company focuses on increasing drug efficacy for large tumor types, like metastatic breast cancer and several orphan cancers, including ovarian and pancreatic cancer, with diagnostic evaluations for cancer patients, specifically addressing drug resistance issues, enabling medical professionals to diagnose and treat cancer effectively.
Contact Information
Website
www.concarlo.comCorporate Office
- Downstate Biotechnology Incubator, 760 Parkside Avenue
- Brooklyn, Suite 208
- New York, NY 11226
- United States
Corporate Office
- Downstate Biotechnology Incubator, 760 Parkside Avenue
- Brooklyn, Suite 208
- New York, NY 11226
- United States
Concarlo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Secondary Transaction - Private | 01-Jun-2026 | Completed | Generating Revenue | |||
| 12. Accelerator/Incubator | 01-Jan-2023 | Completed | Generating Revenue | |||
| 11. Later Stage VC | Completed | Generating Revenue | ||||
| 10. Later Stage VC | 01-May-2022 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 8. Grant | 10-Jul-2020 | Completed | Generating Revenue | |||
| 7. Grant | 10-Jul-2020 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 17-Dec-2019 | Completed | Generating Revenue | |||
| 5. Seed Round | 16-Mar-2018 | $7M | $7.45M | Completed | Generating Revenue | |
| 4. Angel (individual) | 23-Mar-2017 | $450K | $450K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Concarlo Therapeutics Comparisons
Industry
Financing
Details
Concarlo Therapeutics Competitors (2)
One of Concarlo Therapeutics’s 2 competitors is Incyclix Bio, a Venture Capital-Backed company based in Durham, NC.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Incyclix Bio | Venture Capital-Backed | Durham, NC | ||||
| Blueprint Medicines | Formerly VC-backed | Cambridge, MA |
Concarlo Therapeutics Signals
Concarlo Therapeutics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Creative Destruction Lab | Accelerator/Incubator | |||
| Springboard Enterprises | Accelerator/Incubator | Minority | ||
| National Institute on Drug Abuse (NIDA) | Government | |||
| BioAdvance Capital (Conshohocken) | Venture Capital | Minority | ||
| Catalytic Impact Foundation | Not-For-Profit Venture Capital | Minority |
Concarlo Therapeutics FAQs
-
When was Concarlo Therapeutics founded?
Concarlo Therapeutics was founded in 2015.
-
Where is Concarlo Therapeutics headquartered?
Concarlo Therapeutics is headquartered in New York, NY.
-
What is the size of Concarlo Therapeutics?
Concarlo Therapeutics has 7 total employees.
-
What industry is Concarlo Therapeutics in?
Concarlo Therapeutics’s primary industry is Drug Discovery.
-
Is Concarlo Therapeutics a private or public company?
Concarlo Therapeutics is a Private company.
-
What is Concarlo Therapeutics’s current revenue?
The current revenue for Concarlo Therapeutics is .
-
How much funding has Concarlo Therapeutics raised over time?
Concarlo Therapeutics has raised $7.69M.
-
Who are Concarlo Therapeutics’s investors?
Creative Destruction Lab, Springboard Enterprises, National Institute on Drug Abuse (NIDA), BioAdvance Capital (Conshohocken), and Catalytic Impact Foundation are 5 of 7 investors who have invested in Concarlo Therapeutics.
-
Who are Concarlo Therapeutics’s competitors?
Incyclix Bio and Blueprint Medicines are competitors of Concarlo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process